Registration for a live webinar on 'Precision medicine treatment for anticancer drug resistance' is now open.
See webinar detailsWe noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
Printable Handouts
Navigable Slide Index
- Introduction
- The human kinome
- TGF-beta - a paradigm for multifunctionality
- TGF-beta in tissue homeostasis
- TGF-beta inhibits cell proliferation
- TGF-beta induces cell cycle arrest
- Two sets of CDK inhibitors in TGF-beta action
- Discovering TGF-beta receptors
- Mechanism of TGF-beta receptor activation
- TGF-beta receptor activation switch
- TGF-beta signaling pathway (1)
- TGF-beta signaling pathway (2)
- Smad protein structure and functions
- Identifying a Smad DNA-binding cofactor
- Smad DNA-binding cofactors
- Context-dependent Smad transcriptional action
- A TGF-beta transcriptional program
- TGF-beta signaling: cytostatic gene responses
- Smad pathway cofactors and regulators
- Smad linker phosphorylation
- HECT ubiquitin ligases recognize linker-pSmads
- Agonist-induced linker phosphorylation
- Linker phosphorylation in mouse embryo
- CDK8/9 mediate linker phosphorylation
- Smurf1, Nedd4L bind to CDK8/9
- Smurf1 and Nedd4L limit length of Smad activation
- Agonist-induced linker phosphorylation activity
- CDK8/9 is driving the Smad cycle
- Transcriptional CDKs
- Inherited human disorders in TGF-beta and BMP
- Loeys-Dietz syndrome
- TGF-beta and cancer
- Somatic mutations impact TGF-beta-Smad
- TGF-beta in cancer
- Cytostatic gene responses lost in cancer
- TGF-beta-Smad pathway
- Summary
Topics Covered
- The TGFb family as a paradigm of multifunctional cytokines
- TGFb controlling embryo development and tissue homeostasis
- TGFb receptor serine/threonine kinases
- SMADs as central TGFb signal transducers and transcriptional mediators
- Logic and organization of TGFb signaling processes
- TGFb pathway regulation and integration in the cell
- TGFb pathway disruption in heritable disorders and cancer
Talk Citation
Massagué, J. (2010, November 30). SMAD phosphorylation and the TGF-beta pathway [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved December 22, 2024, from https://doi.org/10.69645/NEGG3658.Export Citation (RIS)
Publication History
Financial Disclosures
- Prof. Joan Massagué has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.
Other Talks in the Series: The Molecular Basis of Cancer
Transcript
Please wait while the transcript is being prepared...
0:00
Hello. Welcome to the lecture on
SMAD Phosphorylation
and the TGF-β Pathway.
This is your host Joan Massagué.
0:10
The human genome encodes
about 500 different
protein kinases.
Of these, close to 100 are
tyrosine (tyr) kinases,
of which about half
serve as receptors
for growth factors.
They are transmembrane
tyrosine kinases.
The rest, the majority are
serine/threonine kinases
and only a few of these are in
fact transmembrane receptors.
A majority of these receptors
form a family shown as
a single branch in the
human kinome map and
this family all of its
members serve as receptors
for a very important family of
cytokines which is
the TGFβ family.
0:55
TGFβ is the acronym
for transforming
growth factor beta, a cytokine,
and the founding member of
a large family of factors,
more than 30, encoded in
the human genome.
Factors that play
pivotal roles in many aspects of
embryo development as well as
tissue maintenance
or homeostasis.
TGFβ and its family members are
a paradigm of
multifunctionality in biology.
For example, TGFβ activin and
nodal as well as
the related bone
morphogenetic proteins or
BMPs play very important
roles in laying down
the symmetry axis in
early embryo development.
Anterior-posterior, left-right,
and dorsoventral axis.
Yet, later in development,
these factors can play
important roles in
negatively controlling cell
growth and tissue growth.
The relative of TGFβ,
known as myostatin,
is an important suppressor
of skeletal muscle development.
Mutations that inactivate
the myostatin pathway
give rise to excessive
skeletal tissue mass,
as in for example,
in certain breeds of cattle
developed for this purpose.
The multifunctionality
of these factors
also becomes evident in disease.
For example, TGFβ,
which is normally a
powerful inhibitor of
a number of epithelial tissues
and their growth can become
a strong promoter of epithelial
cancers or carcinomas
especially during
the metastatic phase
the spread of these
tumors to the bone.
As we see in this example,
cancer cells are
acting to destroy
the bone matrix and
TGFβ released from
the bone matrix
can act in turn on the cancer
cells to further promote
their action and the destruction
of the bone through the
outgrowth of metastasis.
How cells respond to